HDFCBANK 1,910.35 -6.00 (-0.31%) 
RELIANCE 1,300.05 -1.60 (-0.12%) TCS 3,447.35 +46.10 (1.36%) HINDUNILVR 2,331.60 +6.35 (0.27%) BPCL 295.40 -6.55 (-2.17%) HDFC 2,729.95 -17.05 (-0.62%) DMART 4,373.55 -123.30 (-2.74%) NESTLEIND 2,414.20 -20.60 (-0.85%) ITC 428.15 -1.95 (-0.45%) HDFCLIFE 705.00 -3.20 (-0.45%) ICICIBANK 1,404.55 +2.30 (0.16%) BHARTIARTL 1,815.60 -29.20 (-1.58%) ONGC 246.35 -3.00 (-1.20%) SBIN 798.75 -14.45 (-1.78%) ASIANPAINT 2,430.20 -34.40 (-1.40%) POWERGRID 306.25 -8.05 (-2.56%) MARUTI 11,685.90 -214.90 (-1.81%) BAJFINANCE 9,111.20 -186.90 (-2.01%) SUNPHARMA 1,786.85 -17.65 (-0.98%) HCLTECH 1,579.30 -7.60 (-0.48%) WIPRO 240.80 -1.95 (-0.80%) KOTAKBANK 2,203.00 -21.00 (-0.94%) NTPC 356.30 -6.75 (-1.86%) BAJAJFINSV 2,045.35 -60.05 (-2.85%) AXISBANK 1,165.30 -42.00 (-3.48%) LT 3,272.15 -28.40 (-0.86%) BRITANNIA 5,419.75 -43.80 (-0.80%) TITAN 3,362.15 -22.20 (-0.66%) ULTRACEMCO 12,236.20 +73.05 (0.60%) Download Unicorn Signals App
By EquityPandit
Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US FDA, after the inspection of its Panelav plant.
The inspection by USFDA was carried out at the formulation facility during the period from March 12 to March 20, 2018. Further, its API facility which is also located at Panelav, had received zero observations after the scheduled inspection in April. This scheduled inspection was conducted by USFDA, at API facility during April 16-23.
